ThinkstockPfizer Inc. (NYSE: PFE) reported second quarter 2015 results before markets opened Tuesday morning. The company reported quarterly adjusted diluted earnings per share (EPS) of $0.56 and revenues of $11.9 billion. In the same…
ThinkstockNymox Pharmaceutical Corp. (NASDAQ: NYMX) was one of the best performers on Monday despite a down day in the market. And Nymox is absolutely dominating in 2015 in terms of its performance, as of Friday’s…
Wikimedia CommonsBefore the market opens on Tuesday morning, Pfizer Inc. (NYSE: PFE) is scheduled to report second-quarter results. The company is expected to post earnings per share (EPS) of $0.52 on revenues of $11.42…
ThinkstockMerck & Co. Inc. (NYSE: MRK) reports on Tuesday morning comes into earnings with shares up only 2.7% or so year to date, and up only about 1.7% from a year ago. Thomson Reuters…
ThinkstockRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NYSE: SNY) announced last Friday that the U.S. Food and Drug Administration (FDA) approved Praluent (alirocumab) Injection. Praluent is indicated as an adjunct to diet and maximally…
ThinkstockTeladoc Inc. (NYSE: TDOC) was a hot initial public offering this summer, and shares remain 50% higher than at the time of the IPO. The company sold some 8,250,000 shares of common stock at…
ThinkstockAimmune Therapeutics, Inc. filed an S-1 form with the Securities and Exchange Commission (SEC) for its initial public offering. The expected price range was set as $14 to $16 for 8.33 million shares with…
ThinkstockThe short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through clinical trials. There is…
ThinkstockThe short interest data are out for the July 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can make or break them.…
In a deal which had been anticipated, Teva Pharmaceutical Industries (NYSE: TEVA) announced it would buy Allergan Generics in a transaction valued at $40.5 billion. According to a press release issued by the two…
ThinkstockPharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings from Dow Jones Industrial Average companies Merck & Co. Inc. (NYSE: MRK) and Pfizer…
Sunesis Pharmaceuticals probably wishes that this Friday never happened, as shares were down almost 70% just after the opening bell.
AbbVie reported better-than-expected second-quarter financial results Friday before the markets opened.
Biogen reported mixed second-quarter 2015 results before markets opened Friday morning.
Biogen is scheduled to release its second-quarter financial results before the markets open on Friday.